Biomics Biopharma (ASX:BBM) Marketable Securities: A$0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biomics Biopharma Marketable Securities?

Biomics Biopharma ASX:BBM Marketable Securities is A$0.00 Mil as of . 20.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Biomics Biopharma's Marketable Securities for the quarter that ended in . 20 was A$0.00 Mil.

Biomics Biopharma  (ASX:BBM) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Biomics Biopharma Marketable Securities Related Terms

Biomics Biopharma Marketable Securities Historical Data

* Premium members only.

The historical data trend for Biomics Biopharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma Marketable Securities Chart

Biomics Biopharma Annual Data
Trend
Marketable Securities

Biomics Biopharma Semi-Annual Data
Marketable Securities

Biomics Biopharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of A$0.00 Mil mean?
Biomics Biopharma (ASX:BBM) has a Marketable Securities of A$0.00 Mil as of . 20. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Biomics Biopharma and its competitors.
Is Biomics Biopharma's Marketable Securities too high?
Biomics Biopharma's current Marketable Securities is A$0.00 Mil.
How does Biomics Biopharma's Marketable Securities compare to competitors?
Biomics Biopharma's Marketable Securities of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Biomics Biopharma and its competitors. Biomics Biopharma's current Marketable Securities is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomics Biopharma stock overvalued right now?
Biomics Biopharma (ASX:BBM) has a current Marketable Securities of A$0.00 Mil. The current Marketable Securities is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Biomics Biopharma (ASX:BBM), the current Marketable Securities is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomics Biopharma Business Description

Address 1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.